EuroAPI
Updating the operating model
- Biotechnology
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of EuroAPI's published strategy and is not endorsed by, or produced in cooperation with, EuroAPI. Company website
Strategic priorities
EuroAPI operates across 4 stated priorities, with the most concrete near-term plan anchored on streamlined value-added portfolio.
Concentrating on highly differentiated APIs including Peptides, Oligonucleotides, Prostaglandins, Corticosteroids, Hormones, Vitamin B12, and Opiates while discontinuing 13 non-competitive APIs by 2027 to improve gross margins.
Consolidating from six manufacturing sites to four core strategic facilities (Elbeuf, Vertolaye, Frankfurt, Budapest) to increase capacity utilization from 60% to over 80% and reduce operational complexity.
Pivoting CDMO activities from secondary revenue stream to primary growth engine, targeting over 35% of net sales by 2027 through the Tides platform and BianoGMP acquisition for oligonucleotide capabilities.
-
01
Streamlined Value-Added Portfolio
Concentrating on highly differentiated APIs including Peptides, Oligonucleotides, Prostaglandins, Corticosteroids, Hormones, Vitamin B12, and Opiates while discontinuing 13 non-competitive APIs by 2027 to improve gross margins.
-
02
Rationalized Industrial Footprint
Consolidating from six manufacturing sites to four core strategic facilities (Elbeuf, Vertolaye, Frankfurt, Budapest) to increase capacity utilization from 60% to over 80% and reduce operational complexity.
-
03
CDMO-Led Growth Strategy
Pivoting CDMO activities from secondary revenue stream to primary growth engine, targeting over 35% of net sales by 2027 through the Tides platform and BianoGMP acquisition for oligonucleotide capabilities.
-
04
Organizational Transformation
Transitioning to a leaner, more agile enterprise with operations-focused leadership, including a new CEO and enhanced commercial and digital capabilities to execute the FOCUS-27 plan.
Challenges we see
- Digital Integration
IT/OT Convergence for Real-Time Process Monitoring
EuroAPI operates century-old manufacturing sites that require modernization to achieve real-time monitoring of production batches through connecting shop-floor sensors and machine control systems to corporate networks.
Without IT/OT convergence, EuroAPI cannot unlock predictive maintenance capabilities or big data analytics for optimizing fermentation yields at Elbeuf, and faces compliance gaps with FDA 21 CFR Part 11 requirements for data integrity.
- Digital Operations
Laboratory Informatics Modernization (LIMS/ELN)
The Tides center in Frankfurt and pilot plant in Budapest require implementation of Laboratory Information Management Systems (LIMS) and Electronic Lab Notebooks (ELN) to manage complex CDMO project workflows and automate data capture from analytical instruments.
Manual data entry from mass spectrometers and chromatography systems creates audit risk, slows R&D timelines, and complicates the traceability required for regulatory compliance.
- Compliance Regulatory
Quality Control System Remediation
The Brindisi site incident exposed systemic quality control deficiencies and potential misconduct, requiring a full forensic audit and production suspension that led to asset impairment and guidance suspension.
Quality incidents test regulator and customer trust, risk FDA warning letters, and strain commercial relationships with sophisticated global pharmaceutical clients.
- Operations Manufacturing
Multi-Site Manufacturing Standardization
EuroAPI operates a heterogeneous mix of legacy equipment and new advanced systems across four core strategic sites spanning France, Germany, and Hungary with varying protocols and capabilities.
Without standardized processes between sites, inefficiencies persist, technology transfer slows, and the risk of batch failures rises during the portfolio consolidation transition.
- ESG Energy
Energy Transition and Decarbonization Execution
EuroAPI has committed to SBTi-validated targets of 42% reduction in Scope 1/2 emissions and 25% reduction in Scope 3 emissions by 2030, requiring significant infrastructure investments including the Elbeuf biomass boiler project.
Slipping on the decarbonization roadmap would widen regulatory compliance gaps, increase exposure to energy price volatility, and risk losing eco-conscious pharmaceutical clients seeking sustainable supply chains.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
Legacy Manufacturing System Integration
EuroAPI's manufacturing sites operate with disconnected shop-floor sensors, machine control systems, and legacy SCADA screens that prevent real-time visibility into production batches and hinder predictive maintenance capabilities.
Implement unified IT/OT integration architecture using OPC UA protocols to connect all manufacturing equipment to a central data platform, enabling real-time monitoring, predictive maintenance, and compliance with FDA 21 CFR Part 11 data integrity requirements.
-
CDMO Laboratory Digitalization Gap
The Frankfurt Tides center and Budapest pilot plant lack integrated LIMS and ELN systems, resulting in manual data capture from analytical instruments, research data silos, and audit compliance risks that slow CDMO project delivery.
Deploy integrated Laboratory Information Management Systems (LIMS) and Electronic Lab Notebooks (ELN) to automate data capture from mass spectrometers and chromatography systems, ensuring secure, traceable, and easily accessible research data for regulatory audits.
-
Process Visualization and KPI Monitoring Deficiency
EuroAPI's visualization tools consist of legacy SCADA screens that are rigid, cluttered, and difficult to interpret, creating cognitive overload for operators and preventing real-time process intelligence during critical API manufacturing runs.
Implement modern dashboarding solutions with P&ID-based visualization, integrated biological KPIs, and Golden Batch comparison capabilities to transform retrospective analysis into proactive process control.
-
Quality Compliance Infrastructure Gaps
The Brindisi quality incident revealed systemic gaps in quality control processes, electronic records management, and data integrity that required forensic audits and production suspension, damaging customer trust.
Implement a comprehensive quality compliance platform with automated data capture, real-time GxP verification, and 100% traceability to restore regulator confidence and meet the enhanced compliance demands of sophisticated global pharmaceutical clients.
-
Sustainable Manufacturing Monitoring and Reporting
EuroAPI must track and report progress against SBTi-validated emissions targets across six industrial sites while executing major decarbonization projects like the Elbeuf biomass boiler, requiring comprehensive environmental data management.
Deploy sustainability monitoring infrastructure with real-time energy consumption tracking, emissions calculation automation, and CSRD-compliant reporting capabilities to ensure transparent progress toward 2030 climate targets.
What we'd propose
- Digital CDMO
Unified IT/OT Manufacturing Integration Platform
A comprehensive IT/OT convergence solution connecting EuroAPI's manufacturing equipment across four strategic sites to a central data platform for real-time monitoring, predictive maintenance, and FDA 21 CFR Part 11 compliant data management.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
CDMO Laboratory Digitalization Suite
An integrated laboratory informatics solution deploying LIMS and ELN systems across EuroAPI's Tides center in Frankfurt and Budapest pilot plant to automate data capture, manage complex CDMO workflows, and ensure regulatory audit readiness.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Advanced Process Intelligence Dashboard
A modern visualization platform replacing legacy SCADA screens with intuitive P&ID-based dashboards, integrated biological KPIs, and Golden Batch comparison capabilities to enable real-time process intelligence during API manufacturing.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
GxP Quality Compliance Platform
A comprehensive quality management solution with automated data capture, real-time GxP verification, and complete traceability to remediate quality control gaps and restore regulator confidence following the Brindisi incident.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Sustainability Monitoring and Reporting Infrastructure
A comprehensive environmental data management platform for tracking energy consumption, calculating emissions, and generating CSRD-compliant reports to ensure transparent progress toward EuroAPI's SBTi-validated 2030 climate targets.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what EuroAPI's own published ambition implies — not a perfect score.
- IT/OT Integration 35 → 80
- Century-old sites lack connected shop-floor systems; FOCUS-27 requires real-time monitoring across four strategic facilities for predictive maintenance and process optimization
- Laboratory Informatics 40 → 85
- Frankfurt Tides center and Budapest pilot plant need LIMS/ELN implementation to manage complex CDMO workflows and automate analytical data capture
- Process Visualization 30 → 75
- Legacy SCADA screens are rigid and cluttered; modern P&ID-based dashboards with integrated KPIs needed for real-time process intelligence
- Quality Compliance Systems 45 → 90
- Brindisi incident exposed quality control gaps; comprehensive remediation with automated data capture and GxP verification required to restore trust
- Data Analytics 35 → 80
- Big data analytics needed for fermentation yield optimization at Elbeuf; historical process data analysis capabilities currently limited
- Sustainability Reporting 40 → 75
- SBTi-validated targets require comprehensive emissions tracking and CSRD-compliant reporting infrastructure across six industrial sites
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Electronic Batch Record (eBR) Readiness
Check how far your batch records are from paperless, and what the next step is.
-
Self-assessment
Find Your LIMS
Answer a few questions about your lab and get a shortlist of LIMS that fit it.
-
Market comparison
European CDMOs Compared
The 2026 landscape: who does what, at what scale.
-
Market comparison
Digital Lab: Equipment & Integration Map
Which lab instruments connect to which systems, and where the gaps usually are.
Think we've read this right?
Talk to usRelated reading
-
OPC UA protocol support in embedded systems
OPC Unified Architecture (OPC UA) is a modern standard for data exchange, increasingly used in industrial environments.
-
From Paper to Performance: Operational Efficiency and Compliance in Labs
Transform your QC lab with scalable digital solutions that embed compliance, boost efficiency, and deliver a future-ready competitive edge.
-
Developing a data and technology-driven flexible lab operations model
Now, when it becomes clear to the biotech companies that only by sharing the data they can thrive, everyone is looking for a solution.
-
Addressing sustainability in pharma & biotech
At A4BEE, we combine company social responsibility and sustainability needs with the path set by the company’s values and mission.
-
Maximizing Competitiveness in the age of Automation
In today's widespread industrial process automation, companies often face the question of how to maximize profits. There are many answers...
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with EuroAPI, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].